SPIRIT 2013 Statement: defining standard protocol items for clinical trials

An Wen Chan, Jennifer M. Tetzlaff, Douglas G. Altman, Andreas Laupacis, Peter C. Gøtzsche, Karmela Krle A-Jerić, Asbjørn Hrobjartsson, Howard Mann, Kay Dickersin, Jesse A. Berlin, Caroline J. Dore, Wendy R. Parulekar, William S.M. Summerskill, Trish Groves, Kenneth F. Schulz, Harold C. Sox, Frank W. Rockhold, Drummond Rennie, David Moher

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Abstract

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol. The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

Original languageEnglish (US)
Pages (from-to)506-514
Number of pages9
JournalRevista panamericana de salud publica = Pan American journal of public health
Volume38
Issue number6
StatePublished - Dec 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'SPIRIT 2013 Statement: defining standard protocol items for clinical trials'. Together they form a unique fingerprint.

Cite this